Filing Details

Accession Number:
0001209191-23-059502
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-21 20:14:54
Reporting Period:
2023-12-20
Accepted Time:
2023-12-21 20:14:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851194 Ventyx Biosciences Inc. VTYX Pharmaceutical Preparations (2834) 832996852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874108 John Nuss C/O Ventyx Biosciences, Inc.
12790 El Camino Real, Suite 200
San Diego CA 92130
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-20 17,628 $2.12 262,118 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stockunits.
  2. Represents the weighted average share price of an aggregate total of 17,628 shares sold in the price range of $2.07 to $2.155. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.